Atrial Septal Defect Clinical Trials 
This is an RSS file. You can use it to subscribe to this data in your favourite RSS reader or to display this data on your own website or blog.
This is an RSS file. You can use it to subscribe to this data in your favourite RSS reader or to display this data on your own website or blog.Clopidogrel For the Prevention of New Onset Migraine Headache Following Transcatheter Closure of Atrial Septal Defects
Condition: MigraineIntervention: Drug: ClopidogrelSponsors: Laval University; Sanofi; Bristol-Myers SquibbActive, not recruiting - verified May 2015 (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - November 26, 2008 Category: Research Source Type: clinical trials
